...A. In the third quarter, Bruker has continued to deliver excellent revenue growth with 3 consecutive quarters of double-digit organic revenue growth year-to-date. B. For the fourth quarter of '23, we anticipate high single-digit organic revenue growth which puts us on track for 3 years of double-digit organic revenue growth in 2021 to 2023. C. In the first 9 months of 2023, we have demonstrated great resilience in difficult market conditions with what we believe is industry-leading organic revenue growth of 13.9% and non-GAAP EPS growth of 17.5% year-to-date. D. Given our strong year-to-date financial results, solid backlog and positive outlook for the fourth quarter, we are raising our organic revenue growth guidance for fiscal year 2023 again, this time by 150 bps at the midpoint. E. We remain positive about demand for Bruker Scientific Instruments and Life Science Solutions, which gives us confidence in the fourth quarter and also for continued solid growth in 2024. F. In fiscal year...